Hot Stocks
Wednesday, May 25, 2016
UPDATE 1-FDA delays decision on Sarepta's muscle-wasting disorder drug
May 25 (Reuters) - The U.S. Food and Drug Administration
deferred its decision on Sarepta Therapeutics Inc's
muscle-wasting disorder drug, a month after a federal advisory
panel determined the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment